Kliničke studije za Гојазност u državi Тексас
84 studija za Гојазност traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
- Houston44 студија
- San Antonio39 студија
- Dallas33 студија
- Austin22 студија
- Grand Prairie13 студија
- The Woodlands12 студија
- Pharr9 студија
- Sugar Land9 студија
- Mesquite9 студија
- El Paso8 студија
- Amarillo7 студија
- Fort Worth7 студија
- Corpus Christi7 студија
- Round Rock5 студија
- McKinney5 студија
- Brownsville5 студија
- Plano4 студија
- Denison4 студија
- League City3 студија
- Garland3 студија
- Tyler3 студија
- Frisco3 студија
- McAllen3 студија
Zvanični tekst studije (na engleskom)
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Cedar Health Research- Texas Native Health, Dallas
- Cedar Health Research, LLC, Dallas
- Soma Clinical Trials, LLC, Denison
- и још 5
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Bellaire Clinical Research, LLC, Bellaire
- South Texas Research Institute - Brownsville, Brownsville
- South Texas Clinical Research, Corpus Christi
- и још 8
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Тражи се учесникЗдраве особе су добродошлеНаводи исплату за учеснике
Узраст од 14 до 16 · Оба пола · Ажурирано 9. 11. 2026. · NCT06943001PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
- Children's Nutrition Research Center, Houston
Тражи се учесникЗдраве особе су добродошле
Узраст од 12 до 18 · Оба пола · Ажурирано 9. 11. 2026. · NCT06959901A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Pinnacle Clinical Research Georgetown, Austin
- Epic Medical Research - DeSoto, DeSoto
- Biopharma Informatic, LLC, Houston
- и још 8
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Velocity Clinical Research, Dallas, Dallas
- DM Clinical Research, Tomball
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07823608A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Mercy Family Clinic, Dallas
- Cedar Health Research, Fort Worth
- JCCT-JUNO NW Houston, Houston
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Advanced Medical Trials, Georgetown
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07854782A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Diabetes and Thyroid Center of Ft. Worth, Fort Worth
- Juno Research, Houston
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellaire Dermatology Associates, Bellaire
- Modern Research Associates, PLLC, Dallas
- Center for Clinical Studies, Houston
- и још 3
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Dell Children's Medical Center - PIN, Austin
- Driscoll Children's Hospital, Corpus Christi
- McGovern Medical School, Houston
- и још 1
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 4. 11. 2026. · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- UT Southwestern Medical Center, Dallas
- Juno Research, Houston
- Activian Clinical Research, Kingwood
- и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- JCCT - Juno Bellaire Site, Bellaire
- Epic Medical Research - DeSoto, DeSoto
- Valley Institute of Research - Fort Worth, Fort Worth
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- FutureSearch Trials of Neurology, Austin
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Dell Children's Medical Center - PIN, Austin
- Driscoll Children's Hospital, Corpus Christi
- McGovern Medical School, Houston
- и још 4
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Fortrea Clinical Research Unit - Dallas, Dallas
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 2. 11. 2026. · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Houston
- Research Site, San Antonio
- Research Site, Sugar Land
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Javara Research, Conroe
- и још 14
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Healthy Living BEYOND Weight Study
- American Heart Association, Dallas
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07075341Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Amarillo Medical Specialists /ID# 282380, Amarillo
- Elligo Clinical Research Center /ID# 282166, Austin
- JCCT - Juno Bellaire /ID# 282263, Bellaire
- и још 6
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- DM Clinical Research, Irving
- DM Clinical Research - Dominion Family Healthcare, San Antonio
- Tekton Research, San Antonio
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight
- Ascletis Clinical Site, San Antonio
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 10. 2026. · NCT07893093Improving Glycemic Control With Electrical Stimulation
- University of Texas at El Paso, El Paso
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT03947697A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Austin
- ACCOMPLISH-2 Research Site, Farmers Branch
- ACCOMPLISH-2 Research Site, Houston
- и још 4
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
- UT MD Anderson, Houston
Тражи се учесникФаза 2
Узраст од 18 до 39 · Оба пола · Ажурирано 20. 10. 2026. · NCT07874828Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
- University of Texas at El Paso, El Paso
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 10. 2026. · NCT06722391Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Amarillo Medical Specialists, Amarillo
- Elligo Clin Res Centre, Austin
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07607587Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Baylor College of Medicine, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06273072A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- ICON Early Phase Services, LLC, San Antonio
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 10. 2026. · NCT07654972The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Elevate Clinical Research, Atascocita, Atascocita
- M3 Wake Research, Dallas
- Epic Medical Research, DeSoto
- и још 4
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- Fortrea Clinical Research Unit, Dallas
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 8. 10. 2026. · NCT07808073Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.